33 related articles for article (PubMed ID: 21087193)
1. Anticancer activity of 8-hydroxyquinoline-triphenylphosphine rhodium(III) complexes targeting mitophagy pathways.
Huang XQ; Wu RC; Liang JM; Zhou Z; Qin QP; Liang H
Eur J Med Chem; 2024 Jun; 272():116478. PubMed ID: 38718624
[TBL] [Abstract][Full Text] [Related]
2. Water-Soluble Gold(III)-Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells.
Hyun Kim J; Ofori S; Mertens RT; Parkin S; Awuah SG
ChemMedChem; 2021 Oct; 16(20):3222-3230. PubMed ID: 34159760
[TBL] [Abstract][Full Text] [Related]
3. A Multitarget Gold(I) Complex Induces Cytotoxicity Related to Aneuploidy in HCT-116 Colorectal Carcinoma Cells.
Zhang JJ; Abu El Maaty MA; Hoffmeister H; Schmidt C; Muenzner JK; Schobert R; Wölfl S; Ott I
Angew Chem Int Ed Engl; 2020 Sep; 59(38):16795-16800. PubMed ID: 32529715
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structural characterization and in vitro cytotoxicity of new Au(III) and Au(I) complexes with thioamides.
Kouroulis KN; Hadjikakou SK; Kourkoumelis N; Kubicki M; Male L; Hursthouse M; Skoulika S; Metsios AK; Tyurin VY; Dolganov AV; Milaeva ER; Hadjiliadis N
Dalton Trans; 2009 Dec; (47):10446-56. PubMed ID: 20023866
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
6. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides.
Hadjikakou SK; Ozturk II; Xanthopoulou MN; Zachariadis PC; Zartilas S; Karkabounas S; Hadjiliadis N
J Inorg Biochem; 2008; 102(5-6):1007-15. PubMed ID: 18279959
[TBL] [Abstract][Full Text] [Related]
8. Mixed ligand-silver(I) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis.
Banti CN; Giannoulis AD; Kourkoumelis N; Owczarzak AM; Poyraz M; Kubicki M; Charalabopoulos K; Hadjikakou SK
Metallomics; 2012 Jun; 4(6):545-60. PubMed ID: 22552402
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
[TBL] [Abstract][Full Text] [Related]
10. Gold(III) Complexes for Antitumor Applications: An Overview.
Bertrand B; Williams MRM; Bochmann M
Chemistry; 2018 Aug; 24(46):11840-11851. PubMed ID: 29575433
[TBL] [Abstract][Full Text] [Related]
11. Square-planar Pd(II), Pt(II), and Au(III) terpyridine complexes: their syntheses, physical properties, supramolecular constructs, and biomedical activities.
Eryazici I; Moorefield CN; Newkome GR
Chem Rev; 2008 Jun; 108(6):1834-95. PubMed ID: 18543874
[No Abstract] [Full Text] [Related]
12. Gold Drugs with {Au(PPh
Stenger-Smith JR; Mascharak PK
ChemMedChem; 2020 Nov; 15(22):2136-2145. PubMed ID: 33025735
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
